Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model

BACKGROUND: While there is an evidence that the anti-inflammatory properties of spironolactone can attenuate proteinuria in type 2 diabetes, its effects on vascular endothelial growth factor (VEGF) expression in diabetic nephropathy have not been clearly defined. In this study, we examined the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mi Young, Shim, Myoung Sook, Kim, Bo Hwan, Hong, Soon Won, Choi, Ran, Lee, Eun Young, Nam, Soo Min, Kim, Gun Woo, Shin, Jang Yel, Shin, Young Goo, Chung, Choon Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122897/
https://www.ncbi.nlm.nih.gov/pubmed/21738895
http://dx.doi.org/10.4093/dmj.2011.35.2.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122897/
https://www.ncbi.nlm.nih.gov/pubmed/21738895
http://dx.doi.org/10.4093/dmj.2011.35.2.130

Ejemplares similares